MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$78,703K
Net Income
$17,290K
Net Profit Margin
21.97%
EPS
$0.88
Unit: Thousand (K) dollars
Revenue Breakdown
Gross Product
Royalty Delivery Of Drug Supplie...
Development Milestones
Revenue Breakdown
Gross Product
Revenue From Contract With Custo...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenues
78,703
58,818
69,802
69,462
Cost of product sales
8,525
4,606
5,955
4,753
Research and development
13,961
11,676
10,685
7,353
Selling, general and administrative
32,642
30,651
29,992
28,936
Total costs and expenses
55,128
46,933
46,632
41,042
Income from operations
23,575
11,885
23,170
28,420
Interest income
789
1,205
1,243
1,094
Interest expense
-
-
-
1,894
Interest expense and other
779
1,433
1,699
-
Income before income taxes
23,585
11,657
22,714
27,620
Provision for income taxes
6,295
3,003
-245,351
-280
Net income
17,290
8,654
268,065
27,900
Basic EPS
0.93
0.47
14.715
1.55
Diluted EPS
0.88
0.44
13.489
1.46
Basic Average Shares
18,541,000
18,412,000
18,217,000
18,038,000
Diluted Average Shares
19,570,000
19,686,000
19,873,000
19,156,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Gross Product
$88,464K
(11.01%↑ Y/Y)
Royalty Delivery Of Drug
Supplies And Others
$7,688K
(178.96%↑ Y/Y)
Development Milestones
$4,000K
Product
$67,015K
(13.68%↑ Y/Y)
Contract Revenues From
Collaborations
$11,688K
(-72.65%↓ Y/Y)
Discounts And Allowances
-$21,449K
(-3.40%↓ Y/Y)
Total revenues
$78,703K
(-22.60%↓ Y/Y)
Income from operations
$23,575K
(-61.42%↓ Y/Y)
Interest income
$789K
(4.78%↑ Y/Y)
Total costs and
expenses
$55,128K
(35.84%↑ Y/Y)
Income before income
taxes
$23,585K
(-60.68%↓ Y/Y)
Interest expense and
other
$779K
Selling, general and
administrative
$32,642K
(11.57%↑ Y/Y)
Research and development
$13,961K
(104.68%↑ Y/Y)
Cost of product sales
$8,525K
(89.28%↑ Y/Y)
Net income
$17,290K
(-71.00%↓ Y/Y)
Provision for income taxes
$6,295K
(1605.96%↑ Y/Y)
Buy us a coffee
RIGEL PHARMACEUTICALS INC (RIGL)
RIGEL PHARMACEUTICALS INC (RIGL)